VVM Vivomedica

 

TIDMVVM 
 
RNS Number : 1058Q 
Vivomedica PLC 
03 April 2009 
 

 
 
3 April 2009 
 
 
VivoMedica plc ('the Company') 
 
 
Result of General Meeting 
 
 
The Company announces that at the general meeting held earlier today 
the resolution to cancel admission of the Company's ordinary shares to trading 
on AIM was duly passed. 
 
 
As a result of the resolution being passed, cancellation of the Company's 
Ordinary Shares to trading on AIM will occur from 15 April 2009 and will be 
effected by a dealing notice being issued at 7am on that day.  Shareholders are 
reminded that they have until the close of business on 14 April 2009 to trade in 
the Company's shares on AIM. 
 
 
The Board are currently exploring the most cost effective way of providing 
shareholders with a platform to continue to trade in the Company's shares and 
will provide details on the Company's website in due course. 
 
 
 
 
For further information, please contact: 
 
 
VivoMedica plc 
Peter Leyland, Chief Executive Officer            01795 414460 
Susan Veness 
 
 
Buchanan Communications 020 7466 5000 
Tim Anderson / Catherine Breen 
 
 
Brewin Dolphin (Nominated Adviser) 
Mark Brady / Alison Barrow   0845 213 4730 
 
 
 
 
END 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCEAELDELPNEFE 
 

Vivomedica (LSE:VVM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Vivomedica (LSE:VVM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024